United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

schering health care ltd - levonorgestrel; ethinylestradiol - oral tablet - 250microgram ; 50microgram

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

merck sharp & dohme (malaysia) sdn bhd - pembrolizumab -

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - temozolomide -

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - temozolomide 100mg - capsule - 100 mg - active: temozolomide 100mg excipient: colloidal silicon dioxide gelatin iron oxide red lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 tekprint black sw-9010 titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - temozolomide 140mg - capsule - 140 mg - active: temozolomide 140mg excipient: colloidal silicon dioxide gelatin indigo carmine lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 tekprint black sw-9010 titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - temozolomide 180mg - capsule - 180 mg - active: temozolomide 180mg excipient: colloidal silicon dioxide gelatin iron oxide red iron oxide yellow lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 tekprint black sw-9010 titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - temozolomide 20mg - capsule - 20 mg - active: temozolomide 20mg excipient: colloidal silicon dioxide gelatin iron oxide yellow lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 tekprint black sw-9010 titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - temozolomide 250mg - capsule - 250 mg - active: temozolomide 250mg excipient: colloidal silicon dioxide gelatin lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 tekprint black sw-9010 titanium dioxide

New Zealand - English - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - temozolomide 5mg - capsule - 5 mg - active: temozolomide 5mg excipient: colloidal silicon dioxide gelatin indigo carmine iron oxide yellow lactose sodium laurilsulfate sodium starch glycolate stearic acid tartaric acid tekprint black sw-9008 tekprint black sw-9010 titanium dioxide

Israel - English - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - temozolomide - capsules - temozolomide 5 mg - temozolomide - temozolomide - temodal capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.